Probiotix Health (AQSE:PBX) Gross-Profit-to-Asset % : 21.88% (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Probiotix Health's annualized Gross Profit for the quarter that ended in Jun. 2023 was £0.53 Mil. Probiotix Health's average Total Assets over the quarter that ended in Jun. 2023 was £2.41 Mil. Therefore, Probiotix Health's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 was 21.88%.

Probiotix Health Gross-Profit-to-Asset % Historical Data

The historical data trend for Probiotix Health's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health Gross-Profit-to-Asset % Chart

Probiotix Health Annual Data

Trend

Dec18

Dec19

Dec20

Dec22

Gross-Profit-to-Asset %

52.33

55.67

Probiotix Health Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial			73.08	58.60	10.65	-	21.88

Competitive Comparison of Probiotix Health's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Probiotix Health's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Probiotix Health's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Probiotix Health's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Probiotix Health's Gross-Profit-to-Asset % falls into.

Probiotix Health Gross-Profit-to-Asset % Calculation

Probiotix Health's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2022 )	/	( (Total Assets (A: Dec. 2020 )	+	Total Assets (A: Dec. 2022 ))	/ count )
	=	0	/	( (0.884	+	2.342)	/ 2 )
	=	0	/	1.613
	=	0.00 %

Probiotix Health's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	0.528	/	( (2.342	+	2.485)	/ 2 )
	=	0.528	/	2.4135
	=	21.88 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Jun. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Probiotix Health Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Probiotix Health's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Probiotix Health (AQSE:PBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

X90:Germany

Address

Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB

Website

https://www.probiotixhealth-ir.com

Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (AQSE:PBX) Headlines

No Headlines